08/03/2017: BioMed Alliance response to the European Medicines Agency’s public consultation: Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products

The European Medicines Agency has released for public consultation a draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products. 

More info here

Subscribe to our email alerts